SHL Telemedicine

SHL Telemedicine develops ECG and supporting devices, platforms, and software for home care. The company aims to increase users' chance of survival in the event of a heart attack and to generally improve quality of life after a medical emergency. SHL systems are intuitive, compact, and sophisticated; the company's ECG devices can record 12 hospital-grade ECGs within seconds. At the heart of the company's service offering is its telemedicine center. The center is staffed around the clock by a skilled, professional, and specially trained medical team to ensure appropriate evaluation and care in line with common medical procedures. Each SHL user receives a complete and secure personal health record that includes all relevant information, including demographic data, medical history, and medical baseline data provided to SHL by its users. This information can also include the results of previous ECGs as well as blood pressure and weight readings. SHL also develops full hospital-grade ECG devices. Such devices allow users to send ECGs remotely to their physician, cardiologist, or telemedicine center for evaluation.

SHL Telemedicine has raised $109M in total funding across 3 rounds. The company is currently at the Public stage. Key investors include More Investment House, Meitav Dash, Valuebase .

SHL Telemedicine was founded in 1987 by Yariv Alroy (Co-founder & CEO).

SHL Telemedicine operates in Health Tech & Life Sciences, Digital Healthcare, Patient Remote Monitoring, Medical Devices, Medical Monitors, Diagnostics Devices, with core technologies in Artificial Intelligence, Platforms & Interfaces, Software, Mobile. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Patients, Insurance Companies.

SHL Telemedicine is based in Yigal Alon 90, Tel Aviv, Israel, Center District. The company also has offices abroad.